New Key Statistics Module, Z-Score and F-Score
SHSE:688192 Key Ratios
Market Cap ¥ M | 18,425.90 |
Enterprise Value ¥ M | 19,809.63 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 30.16 |
Price/Sales | 62.01 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 294.00 |
EPS (TTM) ¥ | -2.29 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -19.60 |
EV-to-EBITDA | -19.60 |
PEG | -- |
Shares Outstanding M | 415.65 |
Net Margin (%) | -318.21 |
Operating Margin % | -348.04 |
Pre-tax Margin (%) | -347.89 |
Quick Ratio | 1.81 |
Current Ratio | 1.87 |
ROA % (ttm) | -57.87 |
ROE % (ttm) | -102.36 |
ROIC % (ttm) | -127.13 |
Dividend Yield % | -- |
Altman Z-Score | 6.74 |
SHSE:688192 Number of Guru Trades
SHSE:688192 Volume of Guru Trades
Gurus Latest Trades with SHSE:688192
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688192 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Dizal (Jiangsu) Pharmaceutical Co Ltd Insider Transactions
No Available Data